Interleukin-2 in Treating Patients With Metastatic Melanoma

NCT00002845 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Melanoma (Skin)

Interventions

BIOLOGICAL: aldesleukin

Sponsor

Blumenthal Cancer Center at Carolinas Medical Center